Öğr. Gör. FAİZE YÜKSEL

Yayın Ağı

Makaleler 24

1. Karaciğer Naklinde ve Kronik Viral Hepatitli Hastalarda Prohepsidin ve Demir Parametrelerinin Değişiminin Araştırılması

ÖZDEMİR Ö., AKARSU M., TOSUN TAŞAR P., Yuksel F., BACAKOĞLU A., ÜNEK T., et al.

Namık Kemal Tıp Dergisi , cilt.11, sa.1, ss.66-71, 2023 (Hakemli Dergi)

2. Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?

Medeni S. S., Turkyilmaz D., Acar C., Sevindik O. G., YÜKSEL F., Piskin O., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.35, sa.4, ss.271-276, 2018 (SCI-Expanded)

3. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood

Gozmen S., Karapinar T. H., TÜFEKÇİ Ö., Vergin C., YÜKSEL F., Irken G., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.27, sa.5, ss.494-499, 2016 (SCI-Expanded, Scopus)

4. Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma

ERÇETİN A. P., ÖZCAN M. A., AKTAŞ S., YÜKSEL F., Solmaz S. M., Sevindik G. O., et al.

EXPERIMENTAL HEMATOLOGY , cilt.44, sa.4, ss.223-230, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion

Katgi A., Sevindik O. G., Gokbulut A. A., ÖZSAN G. H., YÜKSEL F., Solmaz S. M., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.21, sa.7, ss.678-683, 2015 (SCI-Expanded)

6. The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients

Karapinar T. H., KARADAŞ N., Ozek G., TÜFEKÇİ Ö., Atabay B., Turker M., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.25, sa.7, ss.703-708, 2014 (SCI-Expanded, Scopus)

7. Markers of endothelial damage and repair in Takayasu arteritis: Are they associated with disease activity?

Dogan S., Piskin O., Solmaz D., Akar S., GÜLCÜ A., YÜKSEL F., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.34, sa.8, ss.1129-1138, 2014 (SCI-Expanded, Scopus)

8. Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes

AKINCI B., ÇELTİK A., TUNALI S., Genc S., YÜKSEL F., SEÇİL M., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , cilt.289, sa.4, ss.787-793, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

9. The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy

Cankal A., TÜFEKÇİ Ö., Gozmen S., YÜKSEL F., Vergin C., Irken G., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.24, sa.4, ss.375-380, 2013 (SCI-Expanded, Scopus)

10. Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas.

Yener S., ÇÖMLEKÇİ A., YÜKSEL F., Sevinc A. İ., Ertilav S., Yesil S.

European journal of internal medicine , cilt.23, sa.1, ss.83-7, 2012 (SCI-Expanded)

11. Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes

AKINCI B., ÇELTİK A., Yener S., Genc S., TUNALI S., YÜKSEL F., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.17, sa.6, 2011 (SCI-Expanded)

12. The Effect of the Acute Submaximal Exercise on Thrombin Activatable Fibrinolysis Inhibitor Levels in Young Sedentary Males

Kahraman S., BEDİZ C. Ş., Piskin O., AKSU İ., Topcu A., YÜKSEL F., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.17, sa.4, ss.414-420, 2011 (SCI-Expanded)

13. Effect of Levothyroxine Suppression Therapy on Plasma Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels in Benign Thyroid Nodules

AKINCI B., DEMİR T., ÇÖMLEKÇİ A., Yener S., ÖZCAN M. A., Karaoglu O., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.1, ss.23-28, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

14. The Levels of Soluble CD40 Ligand and C-Reactive Protein in Normal Weight, Overweight and Obese People

ÜNEK İ. T., BAYRAKTAR F., Solmaz D., ELLİDOKUZ H., Sisman A., YÜKSEL F., et al.

CLINICAL MEDICINE & RESEARCH , cilt.8, sa.2, ss.89-95, 2010 (ESCI, Scopus)

15. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome

ÜNEK İ. T., BAYRAKTAR F., Solmaz D., ELLİDOKUZ H., YÜKSEL F., Sisman A., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.59, sa.3, ss.305-313, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.

DEMİR T., AKINCI B., ÇÖMLEKÇİ A., Karaoglu O., ÖZCAN M. A., Yener S., et al.

Clinical endocrinology , cilt.71, sa.3, ss.446-50, 2009 (SCI-Expanded)

17. Soluble CD40 ligand plasminogen activator inhibitor 1 and thrombin activatable fibrinolysis inhibitor 1 antigen in normotensive type 2 diabetic subjects without diabetic complications Effects of metformin and rosiglitazone

YENER A. S., ÇÖMLEKÇİ A., AKINCI B., DEMİR T., YÜKSEL F., ÖZCAN M. A., et al.

Med Princ Pract , 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

18. Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications

Yener S., ÇÖMLEKÇİ A., AKINCI B., DEMİR T., YÜKSEL F., ÖZCAN M. A., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.4, ss.266-271, 2009 (SCI-Expanded)

19. Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes

AKINCI B., Demir T., ÇELTİK A., BARIŞ M. M., Yener S., ÖZCAN M. A., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.82, sa.2, ss.172-178, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.

AKINCI B., ÇÖMLEKÇİ A., Yener S., BAYRAKTAR F., DEMİR T., ÖZCAN M. A., et al.

Archives of medical research , cilt.39, sa.4, ss.397-401, 2008 (SCI-Expanded)

21. Plasma thrombin activatable fibrinolysis inhibitor levels in Behcet's disease

ÖZCAN M. A., Akar S., ALACACIOĞLU İ., Pişkin Ö., YÜKSEL F., Gürler O., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.37, sa.5, ss.267-271, 2007 (SCI-Expanded, Scopus, TRDizin)

22. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.

AKINCI B., ÇÖMLEKÇİ A., Yener S., DEMİR T., BAYRAKTAR F., YÜKSEL F., et al.

Hormones (Athens, Greece) , cilt.6, sa.4, ss.327-333, 2007 (SCI-Expanded)

23. Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease

ÖZCAN M. A., AKARSU M., DEMİRKAN F., AKPINAR H., YÜKSEL F., ÖZSAN G. H., et al.

Turkish Journal of Hematology , cilt.23, sa.2, ss.94-99, 2006 (SCI-Expanded)

24. Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients.

Sifil A., Mermut C., Yenicerioglu Y., ÇAVDAR C., GÜMÜŞTEKİN M., Celik A., et al.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis , cilt.19, ss.28-30, 2003 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

315

H-İndeks (WoS)

Atıf (Scopus)

356

H-İndeks (Scopus)

Atıf (Scholar)

134

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler